Welcome

Spectrum Therapeutics is an international medical cannabis company that raises the standard of care for patients with unmet medical needs. We make it easy for patients and healthcare professionals to understand how to optimize the therapeutic benefits of medical cannabis.

Learn more about how Spectrum Therapeutics can help you. Please verify your age to explore the complete website.

Please Enter A Valid Value Please Provide A Value
*

Required Field

I confirm that this is not a shared device.
or
Thank you for visiting Spectrum Therapeutics. You need to be of legal age to enter this site.
Loading...
Spectrum Therapeutics

RAD Pink Haze Blunts | 5 x 1g


THC 18–22 % THC | CBD 0–3 % CBD | |

THC and CBD ranges may vary.

$44.99 /

Pre-rolls

Size Price Quantity
Medical Allotment Deduction

Don’t have an account with us? Register as a new patient or contact our Customer CareCustomer Care

The Spectrum Therapeutics product packaging you receive with your order meets Health Canada's labelling regulations and will vary in appearance from what is displayed online. The images displayed here have been designed to improve your shopping experience by highlighting where your product fits in the Spectrum Framework.

RAD Pink Haze Blunts offer a potent strain with flavours of sweet vanilla and candy, expertly rolled with premium hemp wraps. These blunts are hassle-free and ready to go.

L'emballage des produits Spectrum Therapeutics que vous recevez avec votre commande est conforme aux règlements de Santé Canada en matière d'étiquetage son aspect diffère de ce qui est affiché en ligne. Les images affichées sur cette page ont été élaborées afin d'améliorer votre expérience d'achat en soulignant où se situe le produit dans la gamme Spectrum.

Les blunts RAD Pink Haze offrent une variété puissante aux saveurs de vanille sucrée et de bonbon, roulée de manière experte avec des enveloppes de chanvre de première qualité. Ces blunts sont prêts à l'emploi et ne posent aucun problème.


Quality Assurance Report

Quality Assurance Report